Susquehanna upgrades Idera Pharmaceuticals, Inc. (Nasdaq: IDRA) from Negative to Neutral.

Susquehanna analyst says, "We have always viewed ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE